Q Therapeutics, Inc. Patent Applications Rejected
1 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2018-09-19: Application 16135626; Invention METHODS AND COMPOSITIONS FOR EXPANDING, IDENTIFYING, CHARACTERIZING AND ENHANCING POTENCY OF MAMMALIAN-DERIVED GLIAL RESTRICTED PROGENITOR CELLS; Applicant Q Therapeutics, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2018-09-19 | 16135626 | METHODS AND COMPOSITIONS FOR EXPANDING, IDENTIFYING, CHARACTERIZING AND ENHANCING POTENCY OF MAMMALIAN-DERIVED GLIAL RESTRICTED PROGENITOR CELLS | Q Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190032010A1 | Robert SANDROCK James CAMPANELLI Deborah EPPSTEIN | United States United States United States | TICHY, JENNIFER M.H. |